{"id":"W4364381091","doi":"10.1186/s13045-023-01431-7","title":"Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study","year":2023,"lang":"en","type":"letter","venue":"Journal of Hematology & Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; TG Therapeutics; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Medical College of Wisconsin; StemCyte; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Incyte; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; AstraZeneca; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Hematopoietic cell; Hematology; Myelodysplastic syndromes; Medicine; Internal medicine; Oncology; Hematologic Neoplasms; Haematopoiesis; Genetics; Biology; Stem cell; Transplantation; Bone marrow","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009804519,0.0004297952,0.0005815019,0.00108052,0.0004952099,0.0008482574,0.0005544339,0.0005836742,0.002093239],"category_scores_gemma":[0.00179994,0.0002733529,0.0008497625,0.0008889193,0.0003161453,0.0002174179,0.0006088092,0.0007028426,0.0004562311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003005705,"about_ca_system_score_gemma":0.0004500501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002385656,"about_ca_topic_score_gemma":0.002602894,"domain_scores_codex":[0.9995333,0.00009244082,0.00003201293,0.0001974926,0.0000715861,0.00007317359],"domain_scores_gemma":[0.9993154,0.0001746086,0.0001246698,0.0001147402,0.0000848632,0.0001857435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001988473,0.0004251156,0.9623336,0.00008304856,0.0008161226,0.001142882,0.0003567777,0.0007673118,0.01442515,0.0001448658,0.001400539,0.01611619],"study_design_scores_gemma":[0.0001116856,0.0003312802,0.9948868,0.00001173089,0.0002754706,0.001018498,0.0001699359,0.001633803,0.0005128307,0.00006512255,0.0009685351,0.00001433232],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987497,0.0001349652,0.000202093,0.00004323342,0.000004444731,0.00001633436,0.0007023737,0.000008807585,0.000137991],"genre_scores_gemma":[0.9959732,0.00009469939,0.0004057414,0.0000787561,0.00001937488,0.00002340891,0.003152838,0.00001328315,0.0002388071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002385656,"threshold_uncertainty_score":0.007002532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02929054122277933,"score_gpt":0.3070276284065502,"score_spread":0.2777370871837709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}